Savara Inc logo

Savara Inc

$ 1.61 0 (0%) 11:09 AM EST
P/E:
At Loss
P/B:
1.55
Market Cap:
$ 180.19M
Enterprise V:
$ 75.63M
Volume:
1.53K
Avg Vol (2M):
97.51K
Also Trade In:
Volume:
1.53K
Market Cap $:
180.19M
PE Ratio:
At Loss
Avg Vol (2-Month):
97.51K
Enterprise Value $:
75.63M
PB Ratio:
1.55

Business Description

Description
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Name Current Vs Industry Vs History
Cash-To-Debt 5.14
Equity-to-Asset 0.79
Debt-to-Equity 0.22
Debt-to-EBITDA -0.69
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score -3.56
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 64.58
9-Day RSI 69.01
14-Day RSI 67.56
6-1 Month Momentum % -21.09
12-1 Month Momentum % 10.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 26.55
Quick Ratio 26.55
Cash Ratio 25.97

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -48